Search bioRxiv⌕ Search

Biology subjects

Havel, S.

Publications and source records attributed to Havel, S..

2 recordsLinked to original sources

Enhanced RNA Formation Under Amine-Rich Local Atmospheres from 2',3'- Cyclic Nucleotides

The core biopolymers (DNA, RNA and proteins) are assembled from their monomers under conditions that avoid water. RNA is crucial for the Origin of Life. When cleaved from its polymerized state, RNA first transitions to nucleoside 2,3-cyclic phosphates. In the reverse direction, RNA polymerizes from 2,3-cyclic monomers in dry states, creating short oligomers that then can ligate on a template under aqueous, alkaline conditions. We studied the role of the counterions in polymerization of 2,3-cyclic nucleotides under geologically plausible settings. Through experiments and simulations, we demonstrate that the presence of ammonium and alkylammonium counterions greatly improves RNA polymerization. The otherwise less reactive cytidine containing monomers formed polyC sequences of up to heptamers; copolymers of AU, GC, or GCAU were detected up to hexamers. Our findings suggest three reasons for this: (1) (Alkyl)ammonium cations form hydrogen bonds with phosphates, (2) their alkaline pKa value can trigger general base catalysis, and (3) (alkyl)ammonium salts naturally form dry, anhydrous materials. The findings indicate that pyrolyzed organic tars creating ammonia-rich gas pockets in subsurface rocks could have enhanced the early evolution of RNA. TOC image O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/713775v1_ufig1.gif" ALT="Figure 1"> View larger version (112K): org.highwire.dtl.DTLVardef@1adc431org.highwire.dtl.DTLVardef@12b8da0org.highwire.dtl.DTLVardef@5f187dorg.highwire.dtl.DTLVardef@140ed1a_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗

Discovery of two structurally distinct classes of inhibitors targeting the nuclease MUS81 and enhancing efficacy of chemotherapy in cancer cells

Nucleases are emerging as promising pharmacological targets due to their essential role in maintaining genomic stability, which is crucial for cellular viability and can be exploited in the prevention and treatment of various diseases, including cancer. The conserved structure-specific endonuclease MUS81 is required for resolving branched DNA intermediates during replication, repair, and recombination. Aberrant activity of MUS81 leads to DNA damage, chromosomal abnormalities and genome instability, and contributes to oncogenesis. Pharmacological targeting of MUS81 thus represents an attractive underexplored therapeutic approach. Here we describe the discovery of two chemically distinct classes of small-molecule inhibitors of MUS81, exemplified by the compounds MU262 and MU876. Both compounds can effectively inhibit MUS81 in vitro and in the cell-based context and sensitize cancer cells to DNA-damaging agents through impairing their ability to repair DNA lesions. These compounds can be also used as chemical biology tools for further exploration of MUS81 function, and as leads in the process of drug discovery focused on development of new therapies that exploit DNA repair vulnerabilities in the treatment of cancer.

molecular biology↗